JP2023503963A5 - - Google Patents
Info
- Publication number
- JP2023503963A5 JP2023503963A5 JP2022530318A JP2022530318A JP2023503963A5 JP 2023503963 A5 JP2023503963 A5 JP 2023503963A5 JP 2022530318 A JP2022530318 A JP 2022530318A JP 2022530318 A JP2022530318 A JP 2022530318A JP 2023503963 A5 JP2023503963 A5 JP 2023503963A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated
- antibody
- neisseria
- immunogenic
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025171896A JP2026021348A (ja) | 2019-11-25 | 2025-10-10 | 淋菌感染症に対する免疫原性タンパク質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019904450A AU2019904450A0 (en) | 2019-11-25 | Immunogenic protein against gonococcal infection | |
| AU2019904450 | 2019-11-25 | ||
| PCT/AU2020/051257 WO2021102505A1 (en) | 2019-11-25 | 2020-11-20 | Immunogenic protein against gonococcal infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025171896A Division JP2026021348A (ja) | 2019-11-25 | 2025-10-10 | 淋菌感染症に対する免疫原性タンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023503963A JP2023503963A (ja) | 2023-02-01 |
| JP2023503963A5 true JP2023503963A5 (https=) | 2023-11-28 |
| JP7825273B2 JP7825273B2 (ja) | 2026-03-06 |
Family
ID=76128579
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022530318A Active JP7825273B2 (ja) | 2019-11-25 | 2020-11-20 | 淋菌感染症に対する免疫原性タンパク質 |
| JP2025171896A Pending JP2026021348A (ja) | 2019-11-25 | 2025-10-10 | 淋菌感染症に対する免疫原性タンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025171896A Pending JP2026021348A (ja) | 2019-11-25 | 2025-10-10 | 淋菌感染症に対する免疫原性タンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12479892B2 (https=) |
| EP (1) | EP4065595A4 (https=) |
| JP (2) | JP7825273B2 (https=) |
| KR (1) | KR20220152402A (https=) |
| CN (1) | CN115348968A (https=) |
| AU (1) | AU2020390430A1 (https=) |
| BR (1) | BR112022010167A2 (https=) |
| CA (1) | CA3162559A1 (https=) |
| MX (1) | MX2022006299A (https=) |
| WO (1) | WO2021102505A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023004729A (es) * | 2020-10-23 | 2023-06-29 | Omvax Inc | Composiciones y metodos de vacunacion contra neisseria gonorrhoeae. |
| JP2024526293A (ja) * | 2021-07-05 | 2024-07-17 | エヴァクシオン・バイオテック・アクティエセルスカブ | 淋菌を標的とするワクチン |
| WO2025196270A1 (en) | 2024-03-22 | 2025-09-25 | Limmatech Biologics Ag | Outer membrane vesicle vaccines for the prevention of n. gonorrhoeae and methods of making and using thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047238A (en) | 1983-06-15 | 1991-09-10 | American Home Products Corporation | Adjuvants for vaccines |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5811105A (en) | 1987-12-23 | 1998-09-22 | Glaxo Wellcome, Inc. | Vaccines containing bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pathway |
| US5785973A (en) | 1988-02-01 | 1998-07-28 | Praxis Biologics, Inc. | Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines |
| GB8912330D0 (en) | 1989-05-30 | 1989-07-12 | Wellcome Found | Live vaccines |
| GB9007194D0 (en) | 1990-03-30 | 1990-05-30 | Wellcome Found | Live vaccines |
| AUPO007396A0 (en) | 1996-05-24 | 1996-06-20 | Csl Limited | Ebv ctl epitopes |
| AUPO784197A0 (en) | 1997-07-10 | 1997-08-07 | Csl Limited | Treatment of nasopharyngeal carcinoma |
| EP2261338A3 (en) * | 1998-05-01 | 2012-01-04 | Novartis Vaccines and Diagnostics, Inc. | Neisseria meningitidis antigens and compositions |
| NZ521531A (en) * | 2000-02-28 | 2005-12-23 | Chiron S | Heterologous expression of neisserial proteins |
| EP1962961B1 (en) | 2005-11-29 | 2013-01-09 | The University Of Sydney | Demibodies: dimerisation-activated therapeutic agents |
| JP6687597B2 (ja) * | 2014-07-17 | 2020-04-22 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 髄膜炎菌ワクチン |
| MX2017015404A (es) * | 2015-06-02 | 2018-05-22 | De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport | Visualizacion de superficie de antigenos en vesiculas de membrana externa gram-negativas. |
| CN106606775A (zh) | 2015-10-27 | 2017-05-03 | 格里菲斯大学 | 脂质体a群链球菌疫苗 |
| US12109259B2 (en) * | 2016-09-02 | 2024-10-08 | Glaxosmithkline Biologicals Sa | Vaccines for Neisseria gonorrhoeae |
-
2020
- 2020-11-20 MX MX2022006299A patent/MX2022006299A/es unknown
- 2020-11-20 CN CN202080094488.2A patent/CN115348968A/zh active Pending
- 2020-11-20 JP JP2022530318A patent/JP7825273B2/ja active Active
- 2020-11-20 AU AU2020390430A patent/AU2020390430A1/en active Pending
- 2020-11-20 EP EP20894367.0A patent/EP4065595A4/en active Pending
- 2020-11-20 BR BR112022010167A patent/BR112022010167A2/pt unknown
- 2020-11-20 CA CA3162559A patent/CA3162559A1/en active Pending
- 2020-11-20 US US17/779,411 patent/US12479892B2/en active Active
- 2020-11-20 KR KR1020227021629A patent/KR20220152402A/ko active Pending
- 2020-11-20 WO PCT/AU2020/051257 patent/WO2021102505A1/en not_active Ceased
-
2025
- 2025-10-10 JP JP2025171896A patent/JP2026021348A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5327873B2 (ja) | リコンビナントヘリコバクターピロリの経口ワクチン及びその調製方法 | |
| JP2010516290A5 (https=) | ||
| CN113173977B (zh) | 一种双功能抗原、其制备方法及应用 | |
| JP2023503963A5 (https=) | ||
| CN101863965B (zh) | 幽门螺杆菌尿素酶b抗原表位多肽及其应用 | |
| CN101863963A (zh) | 一种幽门螺杆菌抗原表位多肽及其应用 | |
| JP5661744B2 (ja) | 腸球菌由来のポリペプチド、及びワクチン接種のためのその使用 | |
| CN101863964A (zh) | 一种幽门螺杆菌尿素酶b抗原表位多肽及其应用 | |
| US20160000901A1 (en) | Compositions and Methods for the Production of Virus-Like Particles | |
| Soleimani et al. | Cloning, expression and purification flagellar sheath adhesion of Helicobacter pylori in Escherichia coli host as a vaccination target | |
| CN112316130B (zh) | 一种SARS-CoV2粘膜免疫疫苗及其应用 | |
| KR20160150277A (ko) | 돼지 유행성 설사 바이러스 유래 수용성 재조합 항원 단백질 및 이를 포함하는 돼지 유행성 설사 예방 또는 치료용 백신 조성물 | |
| Barzigar et al. | Transient recombinant expression of highly immunogenic CagA, VacA and NapA in Nicotiana benthamiana | |
| CN105198982B (zh) | 基于il-6的抗原表位及其应用 | |
| CN102847168B (zh) | 一种预防奶牛乳腺炎的核酸疫苗PV-Fn的设计及其构建 | |
| CN115850398B (zh) | 新型冠状病毒奥密克戎系列变异株的多肽组合物及其应用 | |
| CN114437235B (zh) | 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用 | |
| CN107129527B (zh) | 一种马链球菌兽疫亚种保护性抗原hp0623及其制备方法 | |
| CN105218668A (zh) | 马耳他型布氏杆菌的EF-Tu蛋白单克隆抗体MAb及其制备方法与应用 | |
| KR20150123356A (ko) | 오리엔티아 쯔쯔가무시 균에 대한 백신 조성물 | |
| CN101240019B (zh) | 肠出血性大肠杆菌O157:H7志贺毒素2A1亚单位活性片段Stx2a1重组蛋白及表达方法与应用 | |
| US20240092840A1 (en) | Vaccine formulation comprising recombinant overlapping peptides and native proteins | |
| US20250152692A1 (en) | Immunogens targeting anthrax | |
| CN119751703B (zh) | 一种重组蛋白、核酸分子和重组噬菌体及其应用 | |
| CN101445789B (zh) | 显性抑制突变体f427n作为炭疽毒素抑制剂及疫苗的应用 |